Potential of anti-MUC1 antibodies as a targeted therapy for gastrointestinal cancers
M Bose, P Mukherjee - Vaccines, 2020 - mdpi.com
Gastrointestinal cancers (GI) account for 26% of cancer incidences globally and 35% of all
cancer-related deaths. The main challenge is to target cancer specific antigens. Mucins are …
cancer-related deaths. The main challenge is to target cancer specific antigens. Mucins are …